Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02902614
Other study ID # Embryo Biopsy
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2015
Est. completion date December 2, 2018

Study information

Verified date January 2019
Source Al Baraka Fertility Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Selection of side of embryo biopsy that will not interfering with implantation power of developed blastocyst embryo during biopsy procedure arranged for PGT.


Description:

During process of embryo biopsy, it was indicated to avoid contacting cells closer to inner cell mass as it can decrease the quality of embryo and its structural composition. However, recommendation for collection from the trophectoderm (TE) side is indicated.

Absence of differentiation during cleavage-stage or morula stage at day 3 and day 4 respectively, will present the needful to focus a specific location for embryo biopsy during pre-blastocyst stages for embryo going to do genetic testing before implantation or embryo transfer.

In articulation around the second polar body or the animal pole of embryo, collection of the cell from the vegetal pole in crospondence to avoide collection form the animal pole is to be compare the results of implantation for biopsy done using the animal pole side or the random non organized biosy procedure.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 2, 2018
Est. primary completion date December 1, 2018
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- grade 1 or 2 embryos at eight cell stage or 8-1/ 8-2 embryo quality.

Exclusion Criteria:

- grade 3 embryo at day 3, or 8-3 embryos.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Vegetal Pole blastomer embryo
for day 3 embryo biopsy / cleavage stage
Animal Pole blastomer embryo
for day 3 embryo biopsy / cleavage stage

Locations

Country Name City State
Bahrain AHMAD Barakat Manama
Egypt Ibn Sina IVF Center- Ibn Sina Hospital Sohag

Sponsors (2)

Lead Sponsor Collaborator
Ahmad Mustafa Mohamed Metwalley Ibn Sina Hospital

Countries where clinical trial is conducted

Bahrain,  Egypt, 

References & Publications (6)

Balakier H, Sojecki A, Motamedi G, Librach C. Impact of multinucleated blastomeres on embryo developmental competence, morphokinetics, and aneuploidy. Fertil Steril. 2016 Sep 1;106(3):608-614.e2. doi: 10.1016/j.fertnstert.2016.04.041. Epub 2016 May 18. — View Citation

Cimadomo D, Capalbo A, Ubaldi FM, Scarica C, Palagiano A, Canipari R, Rienzi L. The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis. Biomed Res Int. 2016;2016:7193075. doi: 10.1155/2016/7193075. Epub 2016 — View Citation

Dahdouh EM, Balayla J, Audibert F; Genetics Committee, Wilson RD, Audibert F, Brock JA, Campagnolo C, Carroll J, Chong K, Gagnon A, Johnson JA, MacDonald W, Okun N, Pastuck M, Vallée-Pouliot K. Technical Update: Preimplantation Genetic Diagnosis and Scree — View Citation

Geraedts J, Sermon K. Preimplantation genetic screening 2.0: the theory. Mol Hum Reprod. 2016 Aug;22(8):839-44. doi: 10.1093/molehr/gaw033. Epub 2016 Jun 2. Review. — View Citation

Tscherne RJ, Capitano G. High-pressure liquid chromatographic separation of pharmaceutical compounds using a mobile phase containing silver nitrate. J Chromatogr. 1977 Jun 11;136(2):337-41. — View Citation

Wang Z, Ang WT, Tan SY, Latt WT. Automatic segmentation of zona pellucida and its application in cleavage-stage embryo biopsy position selection. Conf Proc IEEE Eng Med Biol Soc. 2015;2015:3859-64. doi: 10.1109/EMBC.2015.7319236. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary blastocyst location of ICM at day 5 describing the location of the inner cell mass (ICM) in location to the zona peluceda (ZP) drilling opening. 2 months
Secondary Implantation power calculating the pregnancy rate for cases after biopsy. 2 months
See also
  Status Clinical Trial Phase
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Recruiting NCT02502214 - Feasibility Study of Preimplantation Genetic Diagnosis for Single-gene Disorders N/A
Recruiting NCT04474522 - RCT of niPGT for Aneuploidy and Morphology Compared With Morphology Alone in IVF N/A